Conversely, for KIT/PDGFRA WT cases with clinical features of a genetic disease, the multigene second-level panel could help to characterize the NF1-related GIST and to make a diagnosis of neurofibromatosis genetic disease. This evidence concerns the gene NF1 and hereditary disease.